Veeva Systems EBITDA 2012-2025 | VEEV
- Veeva Systems EBITDA for the quarter ending January 31, 2025 was $0.198B, a 39.69% increase year-over-year.
- Veeva Systems EBITDA for the twelve months ending January 31, 2025 was $0.722B, a 59.14% increase year-over-year.
- Veeva Systems 2025 annual EBITDA was $0.722B, a 59.14% increase from 2024.
- Veeva Systems 2024 annual EBITDA was $0.454B, a 10.47% decline from 2023.
- Veeva Systems 2023 annual EBITDA was $0.507B, a 10.36% decline from 2022.
Veeva Systems Annual EBITDA (Millions of US $) |
|
---|---|
2025 | $722 |
2024 | $454 |
2023 | $507 |
2022 | $565 |
2021 | $431 |
2020 | $323 |
2019 | $253 |
2018 | $190 |
2017 | $151 |
2016 | $90 |
2015 | $76 |
2014 | $42 |
2013 | $31 |
2012 | $7 |
2011 | $5 |
Veeva Systems Quarterly EBITDA (Millions of US $) |
|
---|---|
2025-01-31 | $198 |
2024-10-31 | $189 |
2024-07-31 | $173 |
2024-04-30 | $161 |
2024-01-31 | $142 |
2023-10-31 | $132 |
2023-07-31 | $109 |
2023-04-30 | $71 |
2023-01-31 | $119 |
2022-10-31 | $132 |
2022-07-31 | $114 |
2022-04-30 | $142 |
2022-01-31 | $135 |
2021-10-31 | $148 |
2021-07-31 | $140 |
2021-04-30 | $143 |
2021-01-31 | $112 |
2020-10-31 | $115 |
2020-07-31 | $103 |
2020-04-30 | $100 |
2020-01-31 | $74 |
2019-10-31 | $89 |
2019-07-31 | $81 |
2019-04-30 | $79 |
2019-01-31 | $70 |
2018-10-31 | $70 |
2018-07-31 | $61 |
2018-04-30 | $52 |
2018-01-31 | $47 |
2017-10-31 | $51 |
2017-07-31 | $46 |
2017-04-30 | $47 |
2017-01-31 | $63 |
2016-10-31 | $38 |
2016-07-31 | $28 |
2016-04-30 | $22 |
2016-01-31 | $19 |
2015-10-31 | $23 |
2015-07-31 | $24 |
2015-04-30 | $23 |
2015-01-31 | $23 |
2014-10-31 | $22 |
2014-07-31 | $18 |
2014-04-30 | $14 |
2014-01-31 | $12 |
2013-10-31 | $11 |
2013-07-31 | $10 |
2013-04-30 | $9 |
2013-01-31 | |
2012-10-31 | $9 |
2012-01-31 | |
2011-01-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $46.097B | $2.747B |
Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Hims & Hers Health (HIMS) | United States | $12.727B | 132.23 |
Tempus AI (TEM) | United States | $11.588B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.708B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.030B | 62.97 |
Hinge Health (HNGE) | United States | $2.965B | 0.00 |
Privia Health (PRVA) | United States | $2.833B | 193.67 |
Enovis (ENOV) | United States | $1.879B | 10.48 |
Schrodinger (SDGR) | United States | $1.869B | 0.00 |
Phreesia (PHR) | United States | $1.636B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.517B | 0.00 |
Omnicell (OMCL) | United States | $1.484B | 26.18 |
Azenta (AZTA) | United States | $1.340B | 62.30 |
10x Genomics (TXG) | United States | $1.242B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.664B | 0.00 |
Claritev (CTEV) | United States | $0.633B | 0.00 |
Butterfly Network (BFLY) | United States | $0.613B | 0.00 |
Talkspace (TALK) | United States | $0.549B | 164.00 |
Veradigm (MDRX) | United States | $0.476B | 0.00 |
Standard BioTools (LAB) | United States | $0.410B | 0.00 |
Outset Medical (OM) | United States | $0.376B | 0.00 |
TruBridge (TBRG) | United States | $0.363B | 805.67 |
Health Catalyst (HCAT) | United States | $0.290B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.139B | 0.00 |
Pulmonx (LUNG) | United States | $0.137B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.125B | 0.00 |
American Well (AMWL) | United States | $0.111B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
CareCloud (CCLD) | United States | $0.092B | 3.52 |
111 (YI) | China | $0.072B | 0.00 |
HeartBeam (BEAT) | United States | $0.054B | 0.00 |
P3 Health Partners (PIII) | United States | $0.047B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
Zhongchao (ZCMD) | China | $0.031B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
Precipio (PRPO) | United States | $0.018B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Movano (MOVE) | United States | $0.005B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |